Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Practice Surveillance of the Use of Herceptin® Subcutaneous in Patients With HER2-Positive Early Breast Cancer (HerSCin)

NCT01959386 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01959386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01959386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Practice Surveillance of the Use of Herceptin® Subcutaneous in Patients With HER2-Positive Early Breast Cancer (HerSCin)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
November 7, 2013
Completion date
January 31, 2019
Enrollment
1,006 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms